根据不同的推测，到2009年(美蒂拓退出市场时)止，500至2000名服用该药的人已经死亡。
By that time, according to different estimates, between 500 and 2, 000 people who had been taking the drug had died.
法国医疗监督机构卫生安全和健康产品委员会（l'Afssaps）劝告那些服用过治疗糖尿病的药物美蒂拓的患者接受心脏瓣膜损伤检查。
The French medical watchdog agency l'Afssaps has recently recommended that patients who took diabetes drug mediator should get tested for heart value damage.
法国医疗监督机构卫生安全和健康产品委员会（l'Afssaps）劝告那些服用过治疗糖尿病的药物美蒂拓的患者接受心脏瓣膜损伤检查。
The French medical watchdog agency l'Afssaps has recently recommended that patients who took diabetes drug mediator should get tested for heart value damage.
应用推荐